45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
7,400
Insurances with rates
20
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 8662112_1 | INJECTION, IPILIMUMAB, 1 MG | $77,125 | $73,269 | — | — | 20 |
| 8340851_1 | USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG | $63,282 | $60,118 | — | — | 20 |
| 6910796_1 | Replacement of knee joint, both sides of knee | $56,651 | $53,818 | — | — | 20 |
| 9001344_1 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $46,513 | $44,187 | — | — | 20 |
| 8662103_1 | INJECTION, OCRELIZUMAB, 1 MG | $44,832 | $42,591 | — | — | 20 |
| 6910797_1 | Replacement of thigh bone and hip joint with prosthesis | $41,973 | $39,874 | — | — | 20 |
| 9034598_1 | INJECTION, TILDRAKIZUMAB, 1 MG | $38,991 | $37,041 | — | — | 20 |
| 7033329_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $35,210 | $33,449 | — | — | 20 |
| 8999675_1 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $31,010 | $29,459 | — | — | 20 |
| 8662193_1 | INJECTION, BRENTUXIMAB VEDOTIN, 1 MG | $26,498 | $25,173 | — | — | 20 |
| 9509052_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $25,950 | $24,653 | — | — | 20 |
| 8662195_1 | INJECTION, ATEZOLIZUMAB, 10 MG | $24,439 | $23,217 | — | — | 20 |
| 9003352_1 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $23,257 | $22,094 | — | — | 20 |
| 8869617_1 | INJECTION, RISANKIZUMAB-RZAA, INTRAVENOUS, 1 MG | $23,092 | $21,938 | — | — | 20 |
| 8664135_1 | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ | $22,962 | $21,814 | — | — | 20 |
| 8341528_1 | INJECTION, VEDOLIZUMAB, INTRAVENOUS, 1 MG | $20,318 | $19,303 | — | — | 20 |
| 8662109_1 | INJECTION, IPILIMUMAB, 1 MG | $19,281 | $18,317 | — | — | 20 |
| 8336812_1 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $19,104 | $18,149 | — | — | 20 |
| 8662104_1 | INJECTION, OBINUTUZUMAB, 10 MG | $18,707 | $17,771 | — | — | 20 |
| 9007451_1 | INJECTION, NATALIZUMAB, 1 MG | $18,544 | $17,617 | — | — | 20 |
| 9493001_1 | INJECTION, TENECTEPLASE, 1 MG | $18,022 | $17,121 | — | — | 20 |
| 9204617_1 | INJECTION, TENECTEPLASE, 1 MG | $18,012 | $17,111 | — | — | 20 |
| 6894541_1 | PURAPLY AM, PER SQUARE CENTIMETER | $17,955 | $17,057 | — | — | 20 |
| 8662194_1 | INJECTION, ATEZOLIZUMAB, 10 MG | $17,107 | $16,252 | — | — | 20 |
| 8662080_1 | INJECTION, NIVOLUMAB, 1 MG | $16,914 | $16,068 | — | — | 20 |
| 8662095_1 | INJECTION, RITUXIMAB 10 MG AND HYALURONIDASE | $16,325 | $15,509 | — | — | 20 |
| 8662096_1 | INJECTION, RAMUCIRUMAB, 5 MG | $15,979 | $15,180 | — | — | 20 |
| 8662100_1 | INJECTION, PANITUMUMAB, 10 MG | $15,740 | $14,953 | — | — | 20 |
| 8999677_1 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $15,505 | $14,730 | — | — | 20 |
| 8664150_1 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $15,006 | $14,255 | — | — | 20 |
| 8337278_1 | INJECTION, PERTUZUMAB, 1 MG | $14,806 | $14,066 | — | — | 20 |
| 8339143_1 | INJECTION, RITUXIMAB 10 MG AND HYALURONIDASE | $14,276 | $13,563 | — | — | 20 |
| 8999682_1 | INJECTION, RISPERIDONE (UZEDY), 1 MG | $14,263 | $13,550 | — | — | 20 |
| 6857918_1 | VIAFLOW MATRIX 2.0CC | $14,189 | $13,480 | — | — | 20 |
| 8862392_1 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $13,940 | $13,243 | — | — | 20 |
| 8337123_1 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $13,932 | $13,236 | — | — | 20 |
| 8662065_1 | INJECTION, ADO-TRASTUZUMAB EMTANSINE, 1 MG | $13,865 | $13,172 | — | — | 20 |
| 7714335_1 | JOINT DEVICE (IMPLANTABLE) | $13,640 | $12,958 | — | — | 20 |
| 8662102_1 | INJECTION, OFATUMUMAB, 10 MG | $13,098 | $12,443 | — | — | 20 |
| 8342038_1 | INJECTION, BENRALIZUMAB, 1 MG | $12,693 | $12,058 | — | — | 20 |
| 9001338_1 | INJECTION, ARIPIPRAZOLE (ABILIFY ASIMTUFII), 1 MG | $12,617 | $11,986 | — | — | 20 |
| 8338425_1 | INJECTION, PEMBROLIZUMAB, 1 MG | $12,552 | $11,924 | — | — | 20 |
| 9316939_1 | INJECTION, ZICONOTIDE, 1 MICROGRAM | $12,031 | $11,429 | — | — | 20 |
| 9481953_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $12,000 | $11,400 | — | — | 20 |
| 9057000_1 | ANCHOR/SCREW FOR OPPOSING BONE-TO-BONE OR SOFT TISSUE-TO-BONE (IMPLANTABLE) | $11,769 | $11,181 | — | — | 20 |
| 9003351_1 | INJECTION, PALIPERIDONE PALMITATE EXTENDED RELEASE (INVEGA HAFYERA, OR INVEGA TRINZA), 1 MG | $11,628 | $11,047 | — | — | 20 |
| 8999681_1 | INJECTION, RISPERIDONE (UZEDY), 1 MG | $11,410 | $10,839 | — | — | 20 |
| 7548254_1 | Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | $10,845 | $10,303 | — | — | 20 |
| 6889008_1 | EPIFIX, PER SQUARE CENTIMETER | $10,437 | $9,915 | — | — | 20 |
| 8337182_1 | INJECTION, RITUXIMAB, 10 MG | $10,198 | $9,688 | — | — | 20 |
Showing top 50 of 7,400 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.